About: http://webisa.webdatacommons.org/82287446

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Do you need to have comparable CR rates in safety to say, a Kyprolis, which in our view is sort of set the bar pretty high, or because of the oral administration, are you willing to take a step down a little bit on response rates?
http://www.w3.org/ns/prov#wasQuotedFrom	seekingalpha.com